Nevertheless, the results of our clinical analyses showed that ECM1a, integrin αXβ2, hnRNPLL, and ABCG1 were positively correlated with each other and that these molecules may be independent prognostic factors for poor survival in patients with ovarian cancer. Here, ABCG1 is linked to ovarian cancer.